4.6 Article

Identification and evaluation of novel drug combinations of Aurora kinase inhibitor CCT137690 for enhanced efficacy in oral cancer cells

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Multidisciplinary Sciences

The 4717C > G polymorphism in periplakin modulates sensitivity to EGFR inhibitors

Hui Mei Lee et al.

SCIENTIFIC REPORTS (2019)

Article Biochemistry & Molecular Biology

Aurora kinase A drives the evolution of resistance to third-generation EGFR inhibitors in lung cancer

Khyati N. Shah et al.

NATURE MEDICINE (2019)

Review Pharmacology & Pharmacy

Recent advances in nanoparticle-mediated drug delivery

Bipul Kumar et al.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2017)

Article Cell Biology

Aurora kinase inhibitor nanoparticles target tumors with favorable therapeutic index in vivo

Susan Ashton et al.

SCIENCE TRANSLATIONAL MEDICINE (2016)

Article Multidisciplinary Sciences

Comprehensive genomic characterization of head and neck squamous cell carcinomas

Michael S. Lawrence et al.

NATURE (2015)

Review Oncology

Aurora Kinase inhibitors: Current Status and Outlook

Vassilios Bavetsias et al.

FRONTIERS IN ONCOLOGY (2015)

Article Oncology

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

Jacques Ferlay et al.

INTERNATIONAL JOURNAL OF CANCER (2015)

Review Biotechnology & Applied Microbiology

Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery

Vladimir P. Torchilin

NATURE REVIEWS DRUG DISCOVERY (2014)

Editorial Material Chemistry, Multidisciplinary

Nanoparticles for Combination Drug Therapy

Liang Ma et al.

ACS NANO (2013)

Review Oncology

Aurora kinases in head and neck cancer

Ranee Mehra et al.

LANCET ONCOLOGY (2013)

Article Multidisciplinary Sciences

Revival of the abandoned therapeutic wortmannin by nanoparticle drug delivery

Shrirang Karve et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)

Article Immunology

AURORA B EXPRESSION AS A PROGNOSTIC INDICATOR AND POSSIBILE THERAPEUTIC TARGET IN ORAL SQUAMOUS CELL CARCINOMA

G. Pannone et al.

INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2011)

Review Oncology

The molecular biology of head and neck cancer

C. Rene Leemans et al.

NATURE REVIEWS CANCER (2011)

Article Otorhinolaryngology

ORAL CAVITY CANCER IN DEVELOPED AND IN DEVELOPING COUNTRIES: POPULATION-BASED INCIDENCE

Marianna de Camargo Cancela et al.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2010)

Article Otorhinolaryngology

AURORA KINASE A INHIBITION AND PACLITAXEL AS TARGETED COMBINATION THERAPY FOR HEAD AND NECK SQUAMOUS CELL CARCINOMA

Abhijit Mazumdar et al.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2009)

Article Pharmacology & Pharmacy

Nanoparticles engineered from lecithin-in-water emulsions as a potential delivery system for docetaxel

Nijaporn Yanasarn et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2009)

Review Medicine, General & Internal

Recent advances in head and neck cancer

Robert I. Haddad et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Review Cell Biology

Aurora-A: the maker and breaker of spindle poles

Alexis R. Barr et al.

JOURNAL OF CELL SCIENCE (2007)

Article Cell Biology

Validating Aurora B as an anti-cancer drug target

Fiona Girdler et al.

JOURNAL OF CELL SCIENCE (2006)

Review Cell Biology

The chromosomal passenger complex: guiding Aurora-B through mitosis

Gerben Vader et al.

JOURNAL OF CELL BIOLOGY (2006)

Review Cell Biology

The cellular geography of aurora kinases

M Carmena et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)